NCT05934214
- Conditions
- Cancer, Immune Checkpoint Inhibitor-Related Myocarditis, Immune-related Adverse Event, +1 more
- Locations
-
- AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France
- CIC Paris-Est / Institut Curie Paris, France